Comorbidity of physical and mental disorders in the neurodevelopmental genomics cohort study

Pediatrics

Volumn 135, Issue 4, 2015, Pages e927-e938

  Merikangas, Kathleen R ^a   Calkins, Monica E ^b   Burstein, Marcy ^a   He, Jian Ping ^a   Chiavacci, Rosetta ^c   Lateef, Tarannum ^a,d   Ruparel, Kosha ^b   Gur, Ruben C ^b   Lehner, Thomas ^a   Hakonarson, Hakon ^b,c   Gur, Raquel E ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDREN GLOBAL ASSESSMENT SCALE; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE REGISTRY; DISEASE SEVERITY; DSM-IV; ELECTRONIC MEDICAL RECORD; FEMALE; FUNCTIONAL DISEASE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL DISEASE ASSESSMENT; MOOD DISORDER; NEURODEVELOPMENTAL DISORDER; NEUROLOGIC DISEASE; PHYSICAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOIMMUNE DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; CHILD BEHAVIOR DISORDERS; CHRONIC DISEASE; DEVELOPMENTAL DISABILITIES; DISABILITY; GENETICS; GENOMICS; MENTAL DISORDERS; MOOD DISORDERS; PENNSYLVANIA; REGISTER; STATISTICS; YOUNG ADULT;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOIMMUNE DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD BEHAVIOR DISORDERS; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEVELOPMENTAL DISABILITIES; DISABILITY EVALUATION; FEMALE; GENOMICS; HUMANS; MALE; MENTAL DISORDERS; MOOD DISORDERS; PHILADELPHIA; REGISTRIES; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84927740554     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1444     Document Type: Article

References (76)

1. Druss BG, Walker ER. Mental disorders and medical comorbidity. Synth Proj Res Synth Rep. 2011 Feb. (21):1-26
2. Affordable Care Act. 2010. Pub L No. 111-148, 124 Stat 119. Available at: www.gpo. gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed October 30, 2014
3. Combs-Orme T, Heflinger CA, Simpkins CG. Comorbidity of mental health problems and chronic health conditions in children. J Emot Behav Disord. 2002;10(2):116-125
4. Friedman AH, Morris TL. Allergies and anxiety in children and adolescents: a review of the literature. J Clin Psychol Med Settings. 2006;13(3):323-335
5. Le Bovidge JS, Lavigne JV, Donenberg GR, Miller ML. Psychological adjustment of children and adolescents with chronic arthritis: a meta-analytic review. J Pediatr Psychol. 2003;28(1):29-39
6. Mackner LM, Sisson DP, Crandall WV. Review: psychosocial issues in pediatric inflammatory bowel disease. J Pediatr Psychol. 2004;29(4):243-257
7. McQuaid EL, Kopel SJ, Nassau JH. Behavioral adjustment in children with asthma: a meta-analysis. J Dev Behav Pediatr. 2001;22(6):430-439
8. Pinquart M. Associations of general parenting and parent-child relationship with pediatric obesity: a meta-analysis. J Pediatr Psychol. 2014;39(4):381-393
9. Pinquart M. Achievement of developmental milestones in emerging and young adults with and without pediatric chronic illness-a metaanalysis. J Pediatr Psychol. 2014;39(6):577-587
10. Pinquart M, Oslejsek B, Teubert D. Efficacy of systemic therapy on adults with mental disorders: a meta-analysis. Psychother Res. 2014; Jul. 17:1-17
11. Rodenburg R, Stams GJ, Meijer AM, Aldenkamp AP, Dekovíc M. Psychopathology in children with epilepsy: a meta-analysis. J Pediatr Psychol. 2005;30(6):453-468
12. Freilinger M, Reisel B, Reiter E, Zelenko M, Hauser E, Seidl R. Behavioral and emotional problems in children with epilepsy. J Child Neurol. 2006;21(11):939-945
13. Bjorgaas HM, Hysing M, Elgen I. Psychiatric disorders among children with cerebral palsy at school starting age. Res Dev Disabil. 2012;33(4):1287-1293
14. Ferro MA, Landgraf JM, Speechley KN. Factor structure of the Child Health Questionnaire Parent Form-50 and predictors of health-related quality of life in children with epilepsy. Qual Life Res. 2013;22(8):2201-2211
15. Letitre SL, De Groot EP, Draaisma E, Brand PL. Anxiety, depression and self-esteem in children with well-controlled asthma: case-control study. Arch Dis Child. 2014;99(8):744-748
16. Pinquart M, Pfeiffer JP. Alcohol use in students with and without hearing loss. J Deaf Stud Deaf Educ. 2015 Jan; 20(1):82-90
17. Cadman D, Boyle M, Szatmari P, Offord DR. Chronic illness, disability, and mental and social well-being: findings of the Ontario Child Health Study. Pediatrics. 1987;79(5):805-813
18. Le Blanc LA, Goldsmith T, Patel DR. Behavioral aspects of chronic illness in children and adolescents. Pediatr Clin North Am. 2003;50(4):859-878
19. Haarasilta L, Marttunen M, Kaprio J, Aro H. Major depressive episode and physical health in adolescents and young adults: results from a population-based interview survey. Eur J Public Health. 2005;15(5):489-493
20. Ford T, Collishaw S, Meltzer H, Goodman R. A prospective study of childhood psychopathology: independent predictors of change over three years. Soc Psychiatry Psychiatr Epidemiol. 2007;42(12):953-961
21. Merikangas KR, Ames M, Cui L, et al. The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry. 2007;64(10):1180-1188
22. Boyce WF, Davies D, Raman SR, et al. Emotional health of Canadian and Finnish students with disabilities or chronic conditions. Int J Rehabil Res. 2009;32(2):154-161
23. Gregory AM, Caspi A, Moffitt TE, Milne BJ, Poulton R, Sears MR. Links between anxiety and allergies: psychobiological reality or possible methodological bias? J Pers. 2009;77(2):347-362
24. Hysing M, Elgen I, Gillberg C, Lundervold AJ. Emotional and behavioural problems in subgroups of children with chronic illness: results from a large-scale population study. Child Care Health Dev. 2009;35(4):527-533
25. Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49, 321 young Swedish men. J Am Coll Cardiol. 2010;56(1):31-37
26. Goodwin RD. Association between infection early in life and mental disorders among youth in the community: a cross-sectional study. BMC Public Health. 2011 Nov. 21; 11:878-882
27. Gur RC, Calkins ME, Satterthwaite TD, et al. Neurocognitive growth charting in psychosis spectrum youths. JAMA Psychiatry. 2014;71(4):366-374
28. Satterthwaite TD, Elliott MA, Ruparel K, et al. Neuroimaging of the Philadelphia neurodevelopmental cohort. Neuroimage. 2014 Feb. 1; 86:544-553
29. Shaffer D, Gould MS, Brasic J, et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-1231
30. Merikangas K, Avenevoli S, Costello J, Koretz D, Kessler RC. National comorbidity survey replication adolescent supplement (NCS-A): I. Background and measures. J Am Acad Child Adolesc Psychiatry. 2009;48(4):367-369
31. Merikangas KR, Dierker LC, Szatmari P. Psychopathology among offspring of parents with substance abuse and/or anxiety disorders: a high-risk study. J Child Psychol Psychiatry. 1998;39(5):711-720
32. Kessler RC, Avenevoli S, Green J, et al. National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments. J Am Acad Child Adolesc Psychiatry. 2009;48(4):386-399
33. Calkins ME, Moore TM, Merikangas KR, et al. The psychosis spectrum in a young U. S.community sample: findings from the Philadelphia Neurodevelopmental Cohort. World Psychiatry. 2014;13(3):296-305
34. Kobayashi H, Nemoto T, Koshikawa H, et al. A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population. Schizophr Res. 2008;106(2-3):356-362
35. Miller TJ, Zipursky RB, Perkins D, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr Res. 2003;61(1):19-30
36. McGlashan TH, Zipursky RB, Perkins D, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res. 2003;61(1):7-18
37. Benjamini Y, Horchberg Y. Controlling for false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser A Stat Soc. 1995; B57(1):289-300
38. Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013 Sep. 12; 11:200215
39. Miller GE, Cole SW. Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol Psychiatry. 2012;72(1):34-40
40. Garg N, Silverberg JI. Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. Ann Allergy Asthma Immunol. 2014;112(6):525-532
41. Reilly C, Atkinson P, Das KB, et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics. 2014;133 (6). Available at: www.pediatrics.org/cgi/content/full/133/6/e1586
42. Fisher HL, Caspi A, Poulton R, et al. Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychol Med. 2013;43(10):2077-2086
43. Kodavali CV, Watson AM, Prasad KM, et al. HLA associations in schizophrenia: are we re-discovering the wheel? Am J Med Genet B Neuropsychiatr Genet. 2014;165B(1):19-27
44. Parker-Athill EC, Tan J. Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Neurosignals. 2010;18(2):113-128
45. Cohen P, Pine DS, Must A, Kasen S, Brook J. Prospective associations between somatic illness and mental illness from childhood to adulthood. Am J Epidemiol. 1998;147(3):232-239
46. Benros ME, Waltoft BL, Nordentoft M, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013;70(8):812-820
47. Konrad K, Eickhoff SB. Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp. 2010;31(6):904-916
48. Chou IC, Chang YT, Chin ZN, et al. Correlation between epilepsy and attention deficit hyperactivity disorder: a population-based cohort study. PLoS ONE. 2013;8(3):e57926
49. Talkowski ME, Rosenfeld JA, Blumenthal I, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell. 2012;149(3):525-537
50. Mick E, Biederman J, Prince J, Fischer MJ, Faraone SV. Impact of low birth weight on attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2002;23(1):16-22
51. Indredavik MS, Vik T, Evensen KA, Skranes J, Taraldsen G, Brubakk AM. Perinatal risk and psychiatric outcome in adolescents born preterm with very low birth weight or term small for gestational age. J Dev Behav Pediatr. 2010;31(4):286-294
52. Loeber R, Dishion T. Early predictors of male delinquency: a review. Psychol Bull. 1983;94(1):68-99
53. Odgers CL, Caspi A, Broadbent JM, et al. Prediction of differential adult health burden by conduct problem subtypes in males. Arch Gen Psychiatry. 2007;64(4):476-484
54. Trzesniewski KH, Moffitt TE, Caspi A, Taylor A, Maughan B. Revisiting the association between reading achievement and antisocial behavior: new evidence of an environmental explanation from a twin study. Child Dev. 2006;77(1):72-88
55. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed). 1987;295(6600):681-682
56. Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatr Res. 1987;21(4):413-421
57. Teplin LA, Abram KM, McClelland GM, Dulcan MK, Mericle AA. Psychiatric disorders in youth in juvenile detention. Arch Gen Psychiatry. 2002;59(12):1133-1143
58. Knop J, Penick EC, Nickel EJ, et al. Childhood ADHD and conduct disorder as independent predictors of male alcohol dependence at age 40. J Stud Alcohol Drugs. 2009;70(2):169-177
59. Fergusson DM, Horwood LJ, Ridder EM. Show me the child at seven: the consequences of conduct problems in childhood for psychosocial functioning in adulthood. J Child Psychol Psychiatry. 2005;46(8):837-849
60. Villodas MT, Pfiffner LJ, McBurnett K. Prevention of serious conduct problems in youth with attention deficit/hyperactivity disorder. Expert Rev Neurother. 2012;12(10):1253-1263
61. Chen H, Cohen P, Crawford TN, Kasen S, Guan B, Gorden K. Impact of early adolescent psychiatric and personality disorder on long-term physical health: a 20-year longitudinal follow-up study. Psychol Med. 2009;39(5):865-874
62. Michailidou K, Hall P, Gonzalez-Neira A, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013 Apr; 45(4):353-361, 361e1-361e2
63. Pharoah PD, Tsai YY, Ramus SJ, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet. 2013 Apr; 45(4):362-370, 370e1-370e2
64. Zhernakova A, Van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet. 2009;10(1):43-55
65. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-712
66. Suvisaari J, Mantere O. Inflammation theories in psychotic disorders: a critical review. Infect Disord Drug Targets. 2013 Feb; 13(1):59-70
67. Lehner T. The genes in the major histocompatibility complex as risk factors for schizophrenia: de omnibus dubitandum. Biol Psychiatry. 2012;72(8):615-616
68. Patterson PH. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res. 2009;204(2):313-321
69. Smoller JW, Craddock N, Kendler K, et al; Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genomewide analysis. Lancet. 2013;381(9875):1371-1379
70. Costello EJ, Edelbrock C, Costello AJ, Dulcan MK, Burns BJ, Brent D. Psychopathology in pediatric primary care: the new hidden morbidity. Pediatrics. 1988;82(3 pt 2):415-424
71. Aupont O, Doerfler L, Connor DF, Stille C, Tisminetzky M, McLaughlin TJ. A collaborative care model to improve access to pediatric mental health services. Adm Policy Ment Health. 2013;40(4):264-273
72. Blau GM, Huang LN, Mallery CJ. Advancing efforts to improve children's mental health in America: a commentary. Adm Policy Ment Health. 2010;37(1-2):140-144
73. Christensen H, Pallister E, Smale S, Hickie IB, Calear AL. Community-based prevention programs for anxiety and depression in youth: a systematic review. J Prim Prev. 2010;31(3):139-170
74. Calear AL, Christensen H. Systematic review of school-based prevention and early intervention programs for depression. J Adolesc. 2010;33(3):429-438
75. Hickie IB, Scott EM, Hermens DF, et al. Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry. 2013;7(1):31-43
76. McGorry P. Beyond DSM: early stages of disorder pose predictable and modifiable risk for persistent disorder. Aust N Z J Psychiatry. 2013 Sep; 47(9):880-881